StockTipsArenaBeta

BUY Piramal Pharma Limited — Motilal Oswal

BUYPiramal Pharma Limited
Piramal Pharma share price target & all analyst calls

byMotilal OswalHorizon: NA (inferred 1 year)15 May 2025via Institutional / Brokerage Research

Entry₹208.61Inferred
Target₹250
Total upside +19.84% (call closed)
Stop lossNot given
At expiry₹174.8715 May 2026, 3:30 pm
Expired-16.17%
Follow Motilal Oswal for new calls(62% target hit, 1108 closed calls)Get alertsWatch PPLPHARMA for new buy/sell callsGet alertsSee 5 active Long-term calls on PPLPHARMASee 211 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:39 pm IST
1 supporting2 neutral0 opposing
Supports the BUY call (1)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·30 Apr · 2w ago

Neutral / worth noting (2)

Piramal Pharma Limited announced its financial results for the fourth quarter and full year of FY26 via a press release dated April 28, 2026.

NSE · Press Release·28 Apr · 2w ago

(opens in new tab)

Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·28 Apr · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Piramal Pharma

All analyst calls on Piramal Pharma

More from Motilal Oswal

Every call and its outcome